Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Raised to $202 at Needham & Company Following Earnings

May 4, 2021 2:00 PM
Needham & Company analyst Mike Matson raised the price target on Zimmer Biomet (NYSE: ZBH) to $202.00 (from $192.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles